COCP vs AAPD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
COCP Captures Institutional Edge (2โ1 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cocrystal Pharma, Inc. Common Stock (COCP) driven by superior Growth & Margin, Momentum & Technical while AAPD counters with relative strength in Options & Structure. Fundamentally, COCP trades at N/M Forward P/E with -3063.6% operating margin (+26.9% YoY revenue) versus AAPD at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AAPD sits in UNCLASSIFIED (12th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | COCP | AAPD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $19.6M | N/A | Larger Scale | COCP |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +26.9% | N/A | Higher Growth | COCP |
| Operating Margin (TTM) Profitability | -3063.6% | N/A | Higher Margin | COCP |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | COCP |
| Return on Equity (ROE) Capital Efficiency | -311.7% | N/A | Higher ROE | COCP |
| 52-Week Range Position Momentum | 19% ($1โ$2) | 5% ($10โ$15) | Stronger Trend | COCP |
| Beta / 30D Volatility Risk Regime | 1.04ฮฒ ยท 54% Vol | -0.55ฮฒ ยท 27% Vol | Lower Realized Risk | AAPD |
| Unified Institutional Score Composite Signal | 47.1 / 100 (HOLD) | 43.5 / 100 (HOLD) | Higher Composite | COCP |